AnGes, Inc. (AMGXF)
0.3602
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
AnGes EPS Diluted (Quarterly): -0.0127 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0253 |
| Nxera Pharma Co., Ltd. | -0.1253 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.0331 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.901M |
| Revenue (Quarterly) | 1.568M |
| Total Expenses (Quarterly) | 6.468M |
| Enterprise Value | 116.16M |
| Gross Profit Margin (Quarterly) | 42.74% |
| Profit Margin (Quarterly) | -312.7% |
| Earnings Yield | -159.7% |
| Normalized Earnings Yield | -70.27 |